Pune: A significant decline this year in the registrations for the state-conducted Common Entrance Tests (CETs) for professional courses highlights ch.

The university cited trends in physician ownership and changing career pathways as reasons for its new program, which will be ...

Indian students are increasingly seeking study abroad options beyond the US, UK, Canada, and Australia. New visa policies and rising expenses in these popular destinations are driving this shift.

The ASHP Board of Directors today announced the appointment of Samuel V. Calabrese, BSPharm, MBA, FASHP, CPEL, as executive vice president and CEO, effective May 1, 2026. Calabrese will become ASHP's ...

Researchers developed a chip-based platform, “μPharma,” that rapidly predicts drug response through AI analysis for children ...

Banasthali Vidyapith has opened registrations for its Aptitude Test 2026, with applications closing April 30. The entrance ...

Comprehensive, up-front full-panel NGS across lung cancer stages is preferred to conserve tissue and avoid sequential testing, but payer denials, QNS biopsies, and consent rules delay results.

In a spectacular display of energy, determination, and sportsmanship, Future University Bareilly hosted its grand annual sports festival, Future Olympics 2026, transforming the campus into an ...

Alchemab Therapeutics has appointed Ulrich Wendt, PhD MBA, as Chief Business Officer (CBO) to expand partnerships with biopharma for the development of novel antibody therapeutics. As a proven ...

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 23, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of ...

Dr. Jason W. Smith was named UofL Health CEO in 2025. Smith has served as chief medical officer for UofL Health since its inception in Novemb ...

CTA/IND-enabling studies progress, supported by regulatory interactions with FDA and EMA since Q3 2025, and on track for CTA submission in H1 2026SENS-501 Audiogene trial ongoing; six-month efficacy ...